| Metric | Value (₹ Cr) | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue | 776.25 | 76.5% | 136.4% |
| Total Income | 788.71 | 76.1% | 134.9% |
| Expenditure | 501.21 | 27.4% | 69.0% |
| PBT | 287.49 | 427.8% | 631.5% |
| Net Profit | 212.67 | 424.2% | 664.9% |
| OPM | 39.59% | 22.05pp | 24.04pp |
| NPM | 26.96% | 17.90pp | 18.68pp |
| EPS | 165.76 | 424.2% | 664.9% |
Neuland Labs: FY26 Results, ₹34 Dividend & Capacity Expansion
12 May 2026 · 12 May, 4:20 pm
Summary
Neuland Laboratories Limited reported financial updates for FY26.
Informational and educational content only. Not investment advice.